cycloheximide has been researched along with tamoxifen aziridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katzenellenbogen, BS; Nardulli, AM | 1 |
Borrás, M; el Khissiin, AH; Gol-Winkler, R; Hardy, L; Leclercq, G; Legros, N; Lempereur, F | 1 |
Borrás, M; el Khissiin, A; Laios, I; Leclercq, G; Legros, N; Lempereur, F; Seo, HS | 1 |
3 other study(ies) available for cycloheximide and tamoxifen aziridine
Article | Year |
---|---|
Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
Topics: Affinity Labels; Amino Acids; Animals; Antibodies, Monoclonal; Cycloheximide; Electrophoresis, Polyacrylamide Gel; Female; Immunosorbent Techniques; Kinetics; Molecular Weight; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Uterus | 1986 |
Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
Topics: Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrone; Half-Life; Humans; Intercalating Agents; Kinetics; Molecular Weight; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Tritium; Tumor Cells, Cultured | 1994 |
Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Cell Nucleus; Cycloheximide; Cytosol; Estradiol; Estrogen Antagonists; Estrogens; Half-Life; Humans; Indicators and Reagents; Molecular Weight; Protein Synthesis Inhibitors; Puromycin; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured; Up-Regulation | 1996 |